TELL ME MORE

ABOUT THIS CLINICAL TRIAL for IBS-C in Children

This is an Efficacy and Safety Study of an investigational medicine for Irritable Bowel Syndrom with Constipation in patients ages 6 – 17 years.


 

Irritable Bowel with Constipation (IBS-C in Children)

Clinical Trial for IBS-C in Children

Study Location(s): Bowling Green Kentucky and Evansville Indiana

Irritable bowel syndrome (IBS) is a group of symptoms that occur together, including repeated pain in the abdomen and changes in bowel movements, which may be diarrhea, constipation, or both. With IBS, a child has these symptoms without any visible signs of damage or disease in the digestive tract. Studies suggest that more than 5 percent of children may suffer with IBS.  This study evaluates efficacy and safety of a previously approved medication for adults in children ages 6 – 17 years. Click here for more information on IBS in childrend

There is no cost to participate.  Volunteers receive free investigational medicine and follow-up care.  No insurance needed.  Time and travel reimburrsement up to $350 may be available.

View More Studies

ConditionLocationStatusAge RangeSexMax Compensation 
ADHD
A Long-term active comparitor and dose optimization study to evaluatate safety and efficacy of a non-stimulat medication
Owensboro
Coming Soon
6 - 17$1150Request Info
ADHD
A randomized, double-blind, multicenter, placebo-controlled study to evaluatate efficacy and safety of an investigational medicine in preschool-age children
Bowling Green
Evansville
Owensboro

Coming Soon
4 - 5$400Request Info
ASTHMA
Safety and Efficacy Study of a Fixed Dose Combination (FDC) in Subjects With Asthma
Evansville
Recruiting
5 - 17$800Request Info
COMMON WARTS
Efficacy, Safety and Tolerability Study in Children and Adults with Common Warts
Evansville
Coming Soon
2+$350Request Info
DIABETES (T2DM)
Active Comparitor Study of a Dual Action versus Single Action Investigational Medicine on Glucose Control and Cardiovascular Events in Adults Age 40+ living with Type 2 Diabetes and CV Risk Factors
BowlingGreen
Owensboro

Coming Soon
40 +$600/year (long-term study could last up to 5 years)Request Info
IBD - CROHN'S DISEASE
A Safety and efficacy, placebo-controlled and active-controled comparison study for patients with moderate to severe Crohn's Disease
Owensboro
Evansville

Recruiting
18 - 80$3200Request Info
IBD - ULCERATIVE COLITIS
A Safety and efficacy, placebo-controlled and active-controled comparison study for patients with moderate to severe Ulcerative Colitis
Evansville
Recruiting
18 - 80$1100Request Info
IBS- CONSTIPATION
A Efficacy and safety, placebo-controlled study for patients with constipation due to irritable bowel syndrome
BowlingGreen
Evansville

Recruiting
6 - 17$350Request Info
INFANT FORMULA
Comparison Study
BowlingGreen
Evansville
Owensboro
RecruitingNewbornsVariable up to $150, + formula and diapersRequest Info
INFANT VACCINE
Comparison Study between two meningococcal vaccines
EvansvilleRecruitingNewbornsVariable up to $400Request Info
LUPUS ERYTHEMATOSUS
A Safety, efficacy and dose ranging comparison study for patients with moderate to severely active Systemic Lupus Erythematosus
EvansvilleRecruiting18 - 65$750Request Info
MIGRAINES in CHILDREN
A Double Blind, Placebo Controlled Study of an Investigational Medicine for Pediatric Migraines
BowlingGreen
Owensboro
Evansville

Coming Soon
6 - 17$200/$350Request Info
PRURITUS (CHRONIC ITCH)
An efficacy and safety study for the treatment of chronic itch in adult subjects with atopic dermatitis
Owensboro
Coming Soon
18 - 75$600Request Info
PSORIATIC ARTHRITIS (PsA)
A Phase 4 Clincial Trial for Psoriatic Arthritis in Adults. This is a compartive study in treatment-naive adults with active Psoriatic Arthritis
Evansville
Coming Soon
18+$900Request Info